Share Price and Basic Stock Data
Last Updated: November 3, 2025, 8:23 pm
| PEG Ratio | 2.53 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
CARE Ratings Ltd operates in the rating services industry, providing credit ratings, research, and risk solutions. The company reported a market capitalization of ₹4,643 Cr and a share price of ₹1,547. For the fiscal year ending March 2025, CARE Ratings recorded sales of ₹402 Cr, reflecting a significant rise from ₹332 Cr in the previous fiscal year. The trailing twelve months (TTM) sales stood at ₹417 Cr, indicating a robust upward trend in revenue generation. Quarterly sales figures showed variability, with the highest sales of ₹117 Cr reported for the quarter ending September 2024, while the lowest was ₹55 Cr in June 2022. The company’s operational efficiency is further highlighted by its operating profit margin (OPM) of 39% for the fiscal year 2025, which aligns well with industry standards, typically ranging from 30% to 40%. The ability to maintain steady sales growth amidst fluctuating economic conditions underscores CARE Ratings’ resilience in the rating services sector.
Profitability and Efficiency Metrics
CARE Ratings demonstrated commendable profitability metrics, with a reported net profit of ₹140 Cr for the fiscal year 2025, up from ₹103 Cr in 2024. The net profit margin stood at 34.79%, reflecting strong operational efficiency compared to the sector average, which hovers around 25% to 30%. The company’s return on equity (ROE) was recorded at 17.02%, indicative of effective capital utilization. Additionally, the interest coverage ratio (ICR) was notably high at 97.76x, suggesting that CARE Ratings has ample capacity to meet its interest obligations with its earnings. The cash conversion cycle (CCC) was reported at 29 days, which is favorable and indicates efficient management of receivables and payables. The company’s ability to generate a healthy operating profit of ₹155 Cr for FY 2025 further illustrates its operational strength in a competitive landscape.
Balance Sheet Strength and Financial Ratios
As of March 2025, CARE Ratings maintained a robust balance sheet, with total assets amounting to ₹958 Cr and total liabilities at ₹958 Cr, reflecting a sound financial position. The company’s reserves increased to ₹776 Cr, up from ₹687 Cr in the previous year, signifying a strong retained earnings position. CARE Ratings reported borrowings of ₹24 Cr, which, when compared to its reserves, indicates low financial leverage. The price-to-book value (P/BV) ratio was recorded at 4.09x, which is relatively high but justifiable given the company’s consistent profitability and growth trajectory. The current ratio stood at 7.08, significantly above the typical industry benchmark of 1.5 to 2, indicating strong liquidity. Furthermore, the company’s return on capital employed (ROCE) was reported at 25%, reflecting effective utilization of capital in generating profits, a critical measure for investors assessing financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of CARE Ratings indicates a diverse investor base, with foreign institutional investors (FIIs) holding 23.61% and domestic institutional investors (DIIs) at 31.60%. Public shareholders accounted for 44.79%, demonstrating considerable retail interest. Over the past fiscal periods, FIIs have gradually increased their stake from 17.99% in December 2022 to 23.61% by September 2025, suggesting growing confidence in the company’s prospects. Conversely, DII holdings have shown a slight increase, indicating institutional endorsement of the company’s performance. The total number of shareholders stood at 56,931 as of September 2025. This diversified ownership structure enhances liquidity and stability, which is crucial for investor sentiment. The increasing institutional interest may also indicate a positive outlook for the company’s future performance in the capital markets.
Outlook, Risks, and Final Insight
Looking ahead, CARE Ratings is well-positioned to capitalize on the growing demand for credit ratings in India’s expanding economy. However, potential risks include regulatory changes that may impact the rating industry and increased competition from emerging players. Additionally, macroeconomic factors such as inflation and interest rate fluctuations could pose challenges to revenue growth. The company’s ability to maintain its profitability and efficiency will be critical in navigating these risks. Strengths include its high interest coverage ratio and significant institutional backing, which provide financial stability. On the other hand, the high P/BV ratio may raise concerns over valuation levels. Overall, while CARE Ratings exhibits strong fundamentals and growth potential, it must remain vigilant against industry and economic headwinds to sustain its market position and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of CARE Ratings Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| ICRA Ltd | 6,296 Cr. | 6,519 | 7,272/5,015 | 33.5 | 1,091 | 0.92 % | 23.1 % | 16.8 % | 10.0 |
| CARE Ratings Ltd | 4,818 Cr. | 1,605 | 1,965/1,052 | 33.9 | 269 | 1.12 % | 24.6 % | 18.0 % | 10.0 |
| Industry Average | 5,557.00 Cr | 4,062.00 | 33.70 | 680.00 | 1.02% | 23.85% | 17.40% | 10.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 55 | 85 | 62 | 78 | 66 | 96 | 79 | 90 | 79 | 117 | 96 | 110 | 94 |
| Expenses | 38 | 43 | 48 | 50 | 49 | 55 | 55 | 61 | 57 | 62 | 66 | 62 | 66 |
| Operating Profit | 16 | 42 | 14 | 27 | 18 | 42 | 23 | 29 | 22 | 56 | 30 | 47 | 28 |
| OPM % | 30% | 50% | 22% | 35% | 27% | 43% | 30% | 32% | 28% | 47% | 32% | 43% | 30% |
| Other Income | 8 | 8 | 12 | 10 | 12 | 11 | 14 | 10 | 12 | 12 | 12 | 15 | 14 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 21 | 48 | 23 | 34 | 26 | 50 | 34 | 36 | 30 | 64 | 39 | 59 | 37 |
| Tax % | 33% | 27% | 28% | 41% | 31% | 29% | 30% | 32% | 30% | 27% | 27% | 26% | 29% |
| Net Profit | 14 | 35 | 16 | 20 | 18 | 36 | 24 | 25 | 21 | 47 | 28 | 43 | 26 |
| EPS in Rs | 4.61 | 11.57 | 5.38 | 6.60 | 5.99 | 11.81 | 7.88 | 8.07 | 6.94 | 15.41 | 9.29 | 14.24 | 8.61 |
Last Updated: August 20, 2025, 12:25 pm
Below is a detailed analysis of the quarterly data for CARE Ratings Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 94.00 Cr.. The value appears to be declining and may need further review. It has decreased from 110.00 Cr. (Mar 2025) to 94.00 Cr., marking a decrease of 16.00 Cr..
- For Expenses, as of Jun 2025, the value is 66.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 62.00 Cr. (Mar 2025) to 66.00 Cr., marking an increase of 4.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Mar 2025) to 28.00 Cr., marking a decrease of 19.00 Cr..
- For OPM %, as of Jun 2025, the value is 30.00%. The value appears to be declining and may need further review. It has decreased from 43.00% (Mar 2025) to 30.00%, marking a decrease of 13.00%.
- For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 22.00 Cr..
- For Tax %, as of Jun 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Mar 2025) to 29.00%, marking an increase of 3.00%.
- For Net Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2025) to 26.00 Cr., marking a decrease of 17.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 8.61. The value appears to be declining and may need further review. It has decreased from 14.24 (Mar 2025) to 8.61, marking a decrease of 5.63.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 5:32 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 236 | 261 | 279 | 287 | 333 | 319 | 244 | 248 | 248 | 279 | 332 | 402 | 417 |
| Expenses | 88 | 101 | 105 | 105 | 122 | 144 | 162 | 153 | 168 | 180 | 220 | 247 | 256 |
| Operating Profit | 148 | 160 | 174 | 182 | 211 | 175 | 81 | 96 | 80 | 99 | 112 | 155 | 161 |
| OPM % | 63% | 61% | 62% | 63% | 63% | 55% | 33% | 39% | 32% | 36% | 34% | 39% | 39% |
| Other Income | 36 | 44 | 9 | 34 | 25 | 30 | 31 | 31 | 27 | 38 | 47 | 51 | 53 |
| Interest | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 | 2 |
| Depreciation | 3 | 5 | 4 | 3 | 3 | 3 | 8 | 8 | 8 | 11 | 10 | 12 | 12 |
| Profit before tax | 181 | 197 | 178 | 212 | 233 | 202 | 104 | 119 | 99 | 126 | 147 | 192 | 199 |
| Tax % | 28% | 30% | 33% | 31% | 30% | 32% | 20% | 23% | 22% | 32% | 30% | 27% | |
| Net Profit | 130 | 138 | 120 | 148 | 162 | 138 | 83 | 91 | 77 | 85 | 103 | 140 | 145 |
| EPS in Rs | 44.63 | 47.53 | 40.68 | 50.13 | 55.13 | 46.66 | 27.96 | 30.39 | 25.34 | 28.12 | 33.67 | 45.85 | 47.55 |
| Dividend Payout % | 63% | 166% | 69% | 56% | 100% | 64% | 70% | 56% | 67% | 89% | 53% | 39% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 6.15% | -13.04% | 23.33% | 9.46% | -14.81% | -39.86% | 9.64% | -15.38% | 10.39% | 21.18% | 35.92% |
| Change in YoY Net Profit Growth (%) | 0.00% | -19.20% | 36.38% | -13.87% | -24.27% | -25.04% | 49.49% | -25.02% | 25.77% | 10.79% | 14.75% |
CARE Ratings Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 11% |
| 3 Years: | 18% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 11% |
| 3 Years: | 22% |
| TTM: | 38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 30% |
| 3 Years: | 44% |
| 1 Year: | 55% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 15% |
| 3 Years: | 15% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 1:35 am
Balance Sheet
Last Updated: July 25, 2025, 3:26 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 30 | 30 | 30 | 30 |
| Reserves | 456 | 330 | 379 | 491 | 567 | 521 | 504 | 559 | 618 | 643 | 687 | 776 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 9 | 17 | 20 | 24 |
| Other Liabilities | 96 | 87 | 94 | 64 | 61 | 64 | 85 | 74 | 69 | 80 | 105 | 128 |
| Total Liabilities | 581 | 446 | 502 | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 |
| Fixed Assets | 59 | 65 | 64 | 61 | 60 | 83 | 93 | 85 | 96 | 107 | 109 | 119 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 8 | 4 | 6 | 3 |
| Investments | 459 | 335 | 381 | 466 | 518 | 439 | 339 | 240 | 44 | 44 | 44 | 134 |
| Other Assets | 63 | 46 | 58 | 57 | 79 | 93 | 185 | 343 | 577 | 614 | 683 | 702 |
| Total Assets | 581 | 446 | 502 | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 |
Below is a detailed analysis of the balance sheet data for CARE Ratings Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 30.00 Cr..
- For Reserves, as of Mar 2025, the value is 776.00 Cr.. The value appears strong and on an upward trend. It has increased from 687.00 Cr. (Mar 2024) to 776.00 Cr., marking an increase of 89.00 Cr..
- For Borrowings, as of Mar 2025, the value is 24.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 20.00 Cr. (Mar 2024) to 24.00 Cr., marking an increase of 4.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 128.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 105.00 Cr. (Mar 2024) to 128.00 Cr., marking an increase of 23.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 958.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 842.00 Cr. (Mar 2024) to 958.00 Cr., marking an increase of 116.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 119.00 Cr.. The value appears strong and on an upward trend. It has increased from 109.00 Cr. (Mar 2024) to 119.00 Cr., marking an increase of 10.00 Cr..
- For CWIP, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Mar 2025, the value is 134.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2024) to 134.00 Cr., marking an increase of 90.00 Cr..
- For Other Assets, as of Mar 2025, the value is 702.00 Cr.. The value appears strong and on an upward trend. It has increased from 683.00 Cr. (Mar 2024) to 702.00 Cr., marking an increase of 19.00 Cr..
- For Total Assets, as of Mar 2025, the value is 958.00 Cr.. The value appears strong and on an upward trend. It has increased from 842.00 Cr. (Mar 2024) to 958.00 Cr., marking an increase of 116.00 Cr..
Notably, the Reserves (776.00 Cr.) exceed the Borrowings (24.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 148.00 | 160.00 | 174.00 | 182.00 | 211.00 | 175.00 | 81.00 | 89.00 | 71.00 | 82.00 | 92.00 | 131.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 23 | 22 | 31 | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 | 29 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 23 | 22 | 31 | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 | 29 |
| Working Capital Days | -100 | -82 | -65 | -10 | -1 | 13 | 14 | -3 | 635 | 638 | 591 | 451 |
| ROCE % | 36% | 39% | 46% | 44% | 41% | 35% | 19% | 21% | 16% | 19% | 21% | 25% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Quant Active Fund | 117,502 | 0.1 | 11.64 | 117,502 | 2025-04-22 15:56:59 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 45.89 | 33.77 | 28.17 | 25.45 | 30.38 |
| Diluted EPS (Rs.) | 45.69 | 33.77 | 28.17 | 25.45 | 30.38 |
| Cash EPS (Rs.) | 50.69 | 37.87 | 32.32 | 28.51 | 33.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 269.37 | 240.23 | 228.63 | 220.20 | 201.29 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 269.37 | 240.23 | 228.63 | 220.20 | 201.29 |
| Revenue From Operations / Share (Rs.) | 134.41 | 111.11 | 93.94 | 83.53 | 84.33 |
| PBDIT / Share (Rs.) | 68.85 | 53.20 | 46.22 | 36.02 | 43.13 |
| PBIT / Share (Rs.) | 64.94 | 49.69 | 42.67 | 33.42 | 40.48 |
| PBT / Share (Rs.) | 64.23 | 49.12 | 42.34 | 33.27 | 40.27 |
| Net Profit / Share (Rs.) | 46.77 | 34.36 | 28.77 | 25.91 | 30.88 |
| NP After MI And SOA / Share (Rs.) | 45.85 | 33.67 | 28.12 | 25.33 | 30.38 |
| PBDIT Margin (%) | 51.22 | 47.88 | 49.20 | 43.12 | 51.14 |
| PBIT Margin (%) | 48.31 | 44.72 | 45.43 | 40.01 | 48.00 |
| PBT Margin (%) | 47.78 | 44.20 | 45.07 | 39.82 | 47.75 |
| Net Profit Margin (%) | 34.79 | 30.92 | 30.63 | 31.02 | 36.61 |
| NP After MI And SOA Margin (%) | 34.11 | 30.30 | 29.93 | 30.33 | 36.03 |
| Return on Networth / Equity (%) | 17.02 | 14.01 | 12.42 | 11.59 | 15.20 |
| Return on Capital Employeed (%) | 22.60 | 19.43 | 17.80 | 14.65 | 19.27 |
| Return On Assets (%) | 14.32 | 11.94 | 10.83 | 10.32 | 13.32 |
| Asset Turnover Ratio (%) | 0.44 | 0.41 | 0.33 | 0.31 | 0.34 |
| Current Ratio (X) | 7.08 | 8.57 | 10.19 | 11.01 | 10.34 |
| Quick Ratio (X) | 7.08 | 8.57 | 10.19 | 11.01 | 10.34 |
| Dividend Payout Ratio (NP) (%) | 39.20 | 65.09 | 71.02 | 50.99 | 44.79 |
| Dividend Payout Ratio (CP) (%) | 36.11 | 58.94 | 63.07 | 46.24 | 41.19 |
| Earning Retention Ratio (%) | 60.80 | 34.91 | 28.98 | 49.01 | 55.21 |
| Cash Earning Retention Ratio (%) | 63.89 | 41.06 | 36.93 | 53.76 | 58.81 |
| Interest Coverage Ratio (X) | 97.76 | 92.77 | 137.04 | 230.27 | 205.78 |
| Interest Coverage Ratio (Post Tax) (X) | 67.41 | 60.91 | 86.31 | 166.65 | 148.31 |
| Enterprise Value (Cr.) | 3207.01 | 3284.31 | 1859.53 | 1441.35 | 932.75 |
| EV / Net Operating Revenue (X) | 7.97 | 9.90 | 6.67 | 5.82 | 3.75 |
| EV / EBITDA (X) | 15.56 | 20.68 | 13.55 | 13.50 | 7.34 |
| MarketCap / Net Operating Revenue (X) | 8.19 | 10.06 | 6.84 | 6.13 | 4.88 |
| Retention Ratios (%) | 60.79 | 34.90 | 28.97 | 49.00 | 55.20 |
| Price / BV (X) | 4.09 | 4.65 | 2.84 | 2.34 | 2.06 |
| Price / Net Operating Revenue (X) | 8.19 | 10.06 | 6.84 | 6.13 | 4.88 |
| EarningsYield | 0.04 | 0.03 | 0.04 | 0.04 | 0.07 |
After reviewing the key financial ratios for CARE Ratings Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 45.89. This value is within the healthy range. It has increased from 33.77 (Mar 24) to 45.89, marking an increase of 12.12.
- For Diluted EPS (Rs.), as of Mar 25, the value is 45.69. This value is within the healthy range. It has increased from 33.77 (Mar 24) to 45.69, marking an increase of 11.92.
- For Cash EPS (Rs.), as of Mar 25, the value is 50.69. This value is within the healthy range. It has increased from 37.87 (Mar 24) to 50.69, marking an increase of 12.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.37. It has increased from 240.23 (Mar 24) to 269.37, marking an increase of 29.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.37. It has increased from 240.23 (Mar 24) to 269.37, marking an increase of 29.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 134.41. It has increased from 111.11 (Mar 24) to 134.41, marking an increase of 23.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 68.85. This value is within the healthy range. It has increased from 53.20 (Mar 24) to 68.85, marking an increase of 15.65.
- For PBIT / Share (Rs.), as of Mar 25, the value is 64.94. This value is within the healthy range. It has increased from 49.69 (Mar 24) to 64.94, marking an increase of 15.25.
- For PBT / Share (Rs.), as of Mar 25, the value is 64.23. This value is within the healthy range. It has increased from 49.12 (Mar 24) to 64.23, marking an increase of 15.11.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 46.77. This value is within the healthy range. It has increased from 34.36 (Mar 24) to 46.77, marking an increase of 12.41.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 45.85. This value is within the healthy range. It has increased from 33.67 (Mar 24) to 45.85, marking an increase of 12.18.
- For PBDIT Margin (%), as of Mar 25, the value is 51.22. This value is within the healthy range. It has increased from 47.88 (Mar 24) to 51.22, marking an increase of 3.34.
- For PBIT Margin (%), as of Mar 25, the value is 48.31. This value exceeds the healthy maximum of 20. It has increased from 44.72 (Mar 24) to 48.31, marking an increase of 3.59.
- For PBT Margin (%), as of Mar 25, the value is 47.78. This value is within the healthy range. It has increased from 44.20 (Mar 24) to 47.78, marking an increase of 3.58.
- For Net Profit Margin (%), as of Mar 25, the value is 34.79. This value exceeds the healthy maximum of 10. It has increased from 30.92 (Mar 24) to 34.79, marking an increase of 3.87.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 34.11. This value exceeds the healthy maximum of 20. It has increased from 30.30 (Mar 24) to 34.11, marking an increase of 3.81.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.02. This value is within the healthy range. It has increased from 14.01 (Mar 24) to 17.02, marking an increase of 3.01.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.60. This value is within the healthy range. It has increased from 19.43 (Mar 24) to 22.60, marking an increase of 3.17.
- For Return On Assets (%), as of Mar 25, the value is 14.32. This value is within the healthy range. It has increased from 11.94 (Mar 24) to 14.32, marking an increase of 2.38.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.44. It has increased from 0.41 (Mar 24) to 0.44, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 7.08. This value exceeds the healthy maximum of 3. It has decreased from 8.57 (Mar 24) to 7.08, marking a decrease of 1.49.
- For Quick Ratio (X), as of Mar 25, the value is 7.08. This value exceeds the healthy maximum of 2. It has decreased from 8.57 (Mar 24) to 7.08, marking a decrease of 1.49.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 39.20. This value is within the healthy range. It has decreased from 65.09 (Mar 24) to 39.20, marking a decrease of 25.89.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 36.11. This value is within the healthy range. It has decreased from 58.94 (Mar 24) to 36.11, marking a decrease of 22.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 60.80. This value is within the healthy range. It has increased from 34.91 (Mar 24) to 60.80, marking an increase of 25.89.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 63.89. This value is within the healthy range. It has increased from 41.06 (Mar 24) to 63.89, marking an increase of 22.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 97.76. This value is within the healthy range. It has increased from 92.77 (Mar 24) to 97.76, marking an increase of 4.99.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 67.41. This value is within the healthy range. It has increased from 60.91 (Mar 24) to 67.41, marking an increase of 6.50.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,207.01. It has decreased from 3,284.31 (Mar 24) to 3,207.01, marking a decrease of 77.30.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.97. This value exceeds the healthy maximum of 3. It has decreased from 9.90 (Mar 24) to 7.97, marking a decrease of 1.93.
- For EV / EBITDA (X), as of Mar 25, the value is 15.56. This value exceeds the healthy maximum of 15. It has decreased from 20.68 (Mar 24) to 15.56, marking a decrease of 5.12.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.19. This value exceeds the healthy maximum of 3. It has decreased from 10.06 (Mar 24) to 8.19, marking a decrease of 1.87.
- For Retention Ratios (%), as of Mar 25, the value is 60.79. This value is within the healthy range. It has increased from 34.90 (Mar 24) to 60.79, marking an increase of 25.89.
- For Price / BV (X), as of Mar 25, the value is 4.09. This value exceeds the healthy maximum of 3. It has decreased from 4.65 (Mar 24) to 4.09, marking a decrease of 0.56.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.19. This value exceeds the healthy maximum of 3. It has decreased from 10.06 (Mar 24) to 8.19, marking a decrease of 1.87.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CARE Ratings Ltd:
- Net Profit Margin: 34.79%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.6% (Industry Average ROCE: 23.85%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.02% (Industry Average ROE: 17.4%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 67.41
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 7.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 33.9 (Industry average Stock P/E: 33.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 34.79%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Rating Services | 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Mumbai Maharashtra 400022 | corp.comm@careedge.in http://www.careratings.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Najib Shah | Chairman(NonExe.&Ind.Director) |
| Mr. Mehul Harshadray Pandya | Managing Director & Group CEO |
| Mr. Sobhag Mal Jain | Non Exe.Non Ind.Director |
| Mr. V Chandrasekaran | Ind. Non-Executive Director |
| Ms. Sonal Desai | Ind. Non-Executive Director |
| Dr. M Mathisekaran | Ind. Non-Executive Director |
| Mr. Gurumoorthy Mahalingam | Ind. Non-Executive Director |
| Mr. Manoj Chugh | Ind. Non-Executive Director |
| Mr. Rajiv Bansal | Ind. Non-Executive Director |
| Ms. Indrani Banerjee | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of CARE Ratings Ltd?
CARE Ratings Ltd's intrinsic value (as of 03 November 2025) is 1327.86 which is 17.27% lower the current market price of 1,605.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,818 Cr. market cap, FY2025-2026 high/low of 1,965/1,052, reserves of ₹776 Cr, and liabilities of 958 Cr.
What is the Market Cap of CARE Ratings Ltd?
The Market Cap of CARE Ratings Ltd is 4,818 Cr..
What is the current Stock Price of CARE Ratings Ltd as on 03 November 2025?
The current stock price of CARE Ratings Ltd as on 03 November 2025 is 1,605.
What is the High / Low of CARE Ratings Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CARE Ratings Ltd stocks is 1,965/1,052.
What is the Stock P/E of CARE Ratings Ltd?
The Stock P/E of CARE Ratings Ltd is 33.9.
What is the Book Value of CARE Ratings Ltd?
The Book Value of CARE Ratings Ltd is 269.
What is the Dividend Yield of CARE Ratings Ltd?
The Dividend Yield of CARE Ratings Ltd is 1.12 %.
What is the ROCE of CARE Ratings Ltd?
The ROCE of CARE Ratings Ltd is 24.6 %.
What is the ROE of CARE Ratings Ltd?
The ROE of CARE Ratings Ltd is 18.0 %.
What is the Face Value of CARE Ratings Ltd?
The Face Value of CARE Ratings Ltd is 10.0.